Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery

British Journal of Anaesthesia

Volumn 108, Issue 5, 2012, Pages 830-837

  Bojan, M ^a   Vicca, S ^a   Boulat, C ^a   Gioanni, S ^a   Pouard, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Acute kidney injury; Aprotinin; Blood transfusion; Cardiac surgical procedures; Heart defects, congenital

Indexed keywords

APROTININ; FRESH FROZEN PLASMA;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD COMPONENT THERAPY; CARDIOPULMONARY BYPASS; DIALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION; TREATMENT DURATION;

EID: 84859862769     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes002     Document Type: Article

References (33)

1. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89: 57-64 (Pubitemid 29293309)
2. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-65 (Pubitemid 43145060)
3. Karkouti K, Beattie WS, Dattilo KM, et al. A propensity score case - control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46: 327-38 (Pubitemid 43334084)
4. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 115: 2801-13 (Pubitemid 46876483)
5. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. Can Med Assoc J 2009; 180: 183-93
6. Furnary AP, Wu Y, Hiratzka LF, Grunkemeier GL, Page US 3rd. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation 2007; 116: I127-33 (Pubitemid 47480780)
7. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31 (Pubitemid 351749156)
8. Backer CL, Kelle AM, Stewart RD, et al. Aprotinin is safe in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2007; 134: 1421-6; discussion 6-8
9. Székely A, Sapi E, Breuer T, et al. Aprotinin and renal dysfunction after pediatric cardiac surgery. Paediatr Anaesth 2008; 18: 151-9
10. Guzzetta NA, Evans FM, Rosenberg ES, et al. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis. Anesth Analg 2009; 108: 448-55
11. Manrique A, Jooste EH, Kuch BA, et al. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass. Anesth Analg 2009; 109: 45-52
12. Pasquali SK, Hall M, Li JS, et al. Safety of aprotinin in congenital heart operations: results from a large multicenter database. Ann Thorac Surg 2010; 90: 14-21
13. Martin K, Gertler R, Liermann H, et al. Switch from aprotinin to {varepsilon}-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery. Br J Anaesth 2011; 107: 934-9
14. Lacour-Gayet F, Clarke D, Jacobs J, et al. The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg 2004; 25: 911-24 (Pubitemid 38622328)
15. Pouard P, Mauriat P, Ek F, et al. Normothermic cardiopulmonary bypass and myocardial cardioplegic protection for neonatal arterial switch operation. Eur J Cardiothorac Surg 2006; 30: 695-9 (Pubitemid 44572778)
16. Bojan M, Constanza Basto Duarte M, Lopez Lopez V, Tourneur L, Pouard P, Vouhe P. Use of a miniaturized cardiopulmonary bypass circuit in neonates and infants is associated with fewer blood product transfusions. ASAIO J 2011; 57: 527-32
17. Royston D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1992; 6: 76-100
18. Breuer T, Martin K,Wilhelm M, et al. The blood sparing effect and the safetyof aprotinincompared to tranexamic acid inpaediatric cardiac surgery. Eur J Cardiothorac Surg 2009; 35: 167-71, author reply 71
19. Martin K, Wiesner G, Breuer T, Lange R, Tassani P. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients. Anesth Analg 2008; 107: 1783-90
20. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
21. Drukker A, Guignard JP. Renal aspects of the term and preterm infant: a selective update. Curr Opin Pediatr 2002; 14: 175-82 (Pubitemid 34412161)
22. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer, 2001
23. Austin PC. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies. Stat Med 2010; 29: 2137-48
24. Pedersen KR, Povlsen JV, Christensen S, et al. Risk factors for acute renal failure requiring dialysis after surgery for congenital heart disease in children. Acta Anaesthesiol Scand 2007; 51: 1344-9 (Pubitemid 47609497)
25. Zappitelli M, Bernier PL, Saczkowski RS, et al. A small postoperative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int 2009; 76: 885-92
26. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82
27. Karkouti K, Wijeysundera DN, Yau TM, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology 2011; 115: 523-30
28. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg 2010; 110: 21-9
29. Gagne JJ, Griesdale DE, Schneeweiss S. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies. Pharmacoepidemiol Drug Saf 2009; 18: 259-68
30. Chan KL, Ip P, Chiu CS, Cheung YF. Peritoneal dialysis after surgery for congenital heart disease in infants and young children. Ann Thorac Surg 2003; 76: 1443-9 (Pubitemid 37378291)
31. Picca S, Principato F, Mazzera E, et al. Risks of acute renal failure after cardiopulmonary bypass surgery in children: a retrospective 10-year case-control study. Nephrol Dial Transplant 1995; 10: 630-6
32. Szekely A, Cserep Z, Sapi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg 2009; 87: 187-97
33. Salvin JW, Scheurer MA, Laussen PC, et al. Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg 2011; 91: 204-10